{"entity":{"type":"insider","cik":"0001509917","url":"/insider/0001509917","json_url":"/insider/0001509917.json","name":"Shell William","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":77,"n_filings":8,"first":"2013-07-23","last":"2014-05-28","span_basis":"filed_date"},"name_variants":[{"name":"Shell William","source":"filing","n_filings":8,"first_seen":"2013-07-23","last_seen":"2014-05-28"}],"transactions":[{"id":6687741,"accession":"0001493152-14-001729","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-14-001729","line_url":"/filing/0001493152-14-001729#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509917","owner_name":"Shell William","owner_display_name":"Shell William","owner_url":"/insider/0001509917","role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":1200.0,"total_display":"1,200.00","total_whole":"1,200","shares_owned_after":664764.0,"shares_owned_after_display":"664,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-28","filed_date":"2014-05-28","scope":"insider"},{"id":6292467,"accession":"0001493152-14-001724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-14-001724","line_url":"/filing/0001493152-14-001724#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509917","owner_name":"Shell William","owner_display_name":"Shell William","owner_url":"/insider/0001509917","role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":1950.0,"total_display":"1,950.00","total_whole":"1,950","shares_owned_after":666764.0,"shares_owned_after_display":"666,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-27","scope":"insider"},{"id":6840154,"accession":"0001493152-14-001087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-14-001087","line_url":"/filing/0001493152-14-001087#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509917","owner_name":"Shell William","owner_display_name":"Shell William","owner_url":"/insider/0001509917","role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","total_whole":"90,000","shares_owned_after":669764.0,"shares_owned_after_display":"669,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-10","filed_date":"2014-04-10","scope":"insider"},{"id":5016239,"accession":"0001144204-13-051728","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-13-051728","line_url":"/filing/0001144204-13-051728#line-7","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Elizabeth Charuvastra Marital Trust; William Shell Survivor's Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":1680.0,"total_display":"1,680.00","total_whole":"1,680","shares_owned_after":208000.0,"shares_owned_after_display":"208,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-13","filed_date":"2013-09-20","scope":"insider"},{"id":9236385,"accession":"0001144204-13-049193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-049193","line_url":"/filing/0001144204-13-049193#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28100.0,"shares_display":"28,100","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":32315.0,"total_display":"32,315.00","total_whole":"32,315","shares_owned_after":651054.0,"shares_owned_after_display":"651,054","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-20","filed_date":"2013-09-04","scope":"insider"},{"id":4763164,"accession":"0001144204-13-040766","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766#line-29","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":4150.0,"total_display":"4,150.00","total_whole":"4,150","shares_owned_after":420799.0,"shares_owned_after_display":"420,799","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-26","filed_date":"2013-07-23","scope":"insider"},{"id":4763159,"accession":"0001144204-13-040766","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766#line-28","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":12030.0,"total_display":"12,030.00","total_whole":"12,030","shares_owned_after":419799.0,"shares_owned_after_display":"419,799","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-25","filed_date":"2013-07-23","scope":"insider"},{"id":4763153,"accession":"0001144204-13-040766","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766#line-27","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":16600.0,"total_display":"16,600.00","total_whole":"16,600","shares_owned_after":416799.0,"shares_owned_after_display":"416,799","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-24","filed_date":"2013-07-23","scope":"insider"},{"id":4763150,"accession":"0001144204-13-040766","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":4.163636363636364,"price_display":"4.16","price_state":"stated","total_value":45800.0,"total_display":"45,800.00","total_whole":"45,800","shares_owned_after":412799.0,"shares_owned_after_display":"412,799","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-23","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763142,"accession":"0001144204-13-040766","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":4.298571428571429,"price_display":"4.30","price_state":"stated","total_value":30090.0,"total_display":"30,090.00","total_whole":"30,090","shares_owned_after":403299.0,"shares_owned_after_display":"403,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-22","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763134,"accession":"0001144204-13-040766","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.654,"price_display":"4.65","price_state":"stated","total_value":23270.0,"total_display":"23,270.00","total_whole":"23,270","shares_owned_after":398799.0,"shares_owned_after_display":"398,799","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-19","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763120,"accession":"0001144204-13-040766","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766#line-20","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13500.0,"shares_display":"13,500","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":66285.0,"total_display":"66,285.00","total_whole":"66,285","shares_owned_after":394799.0,"shares_owned_after_display":"394,799","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-18","filed_date":"2013-07-23","scope":"insider"},{"id":4763115,"accession":"0001144204-13-040766","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36500.0,"shares_display":"36,500","price_per_share":4.59986301369863,"price_display":"4.60","price_state":"stated","total_value":167895.0,"total_display":"167,895.00","total_whole":"167,895","shares_owned_after":381299.0,"shares_owned_after_display":"381,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-17","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763107,"accession":"0001144204-13-040766","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38000.0,"shares_display":"38,000","price_per_share":4.4868421052631575,"price_display":"4.49","price_state":"stated","total_value":170500.0,"total_display":"170,500.00","total_whole":"170,500","shares_owned_after":350799.0,"shares_owned_after_display":"350,799","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-16","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763100,"accession":"0001144204-13-040766","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39859.0,"shares_display":"39,859","price_per_share":4.517605308713214,"price_display":"4.52","price_state":"stated","total_value":180067.23,"total_display":"180,067.23","total_whole":"180,067","shares_owned_after":318799.0,"shares_owned_after_display":"318,799","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-15","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763091,"accession":"0001144204-13-040766","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17200.0,"shares_display":"17,200","price_per_share":4.097441860465116,"price_display":"4.10","price_state":"stated","total_value":70476.0,"total_display":"70,476.00","total_whole":"70,476","shares_owned_after":279599.0,"shares_owned_after_display":"279,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-12","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763081,"accession":"0001144204-13-040766","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.944,"price_display":"3.94","price_state":"stated","total_value":59160.0,"total_display":"59,160.00","total_whole":"59,160","shares_owned_after":263399.0,"shares_owned_after_display":"263,399","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-11","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763070,"accession":"0001144204-13-040766","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38249.0,"shares_display":"38,249","price_per_share":3.53448691469058,"price_display":"3.53","price_state":"stated","total_value":135190.59,"total_display":"135,190.59","total_whole":"135,191","shares_owned_after":237250.0,"shares_owned_after_display":"237,250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-10","filed_date":"2013-07-23","scope":"insider","n_lines":3},{"id":4763056,"accession":"0001144204-13-040766","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32500.0,"shares_display":"32,500","price_per_share":2.3166153846153845,"price_display":"2.32","price_state":"stated","total_value":75290.0,"total_display":"75,290.00","total_whole":"75,290","shares_owned_after":215650.0,"shares_owned_after_display":"215,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-09","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763037,"accession":"0001144204-13-040766","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8500.0,"shares_display":"8,500","price_per_share":2.1411764705882352,"price_display":"2.14","price_state":"stated","total_value":18200.0,"total_display":"18,200.00","total_whole":"18,200","shares_owned_after":194150.0,"shares_owned_after_display":"194,150","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-08","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4763026,"accession":"0001144204-13-040766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-040766","line_url":"/filing/0001144204-13-040766","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Shell William; Elizabeth Charuvastra & William Shell Family Trust","owner_display_name":"Shell William","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":2.1028571428571428,"price_display":"2.10","price_state":"stated","total_value":29440.0,"total_display":"29,440.00","total_whole":"29,440","shares_owned_after":186650.0,"shares_owned_after_display":"186,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-05","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4302971,"accession":"0001144204-13-040768","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19100.0,"shares_display":"19,100","price_per_share":2.068167539267016,"price_display":"2.07","price_state":"stated","total_value":39502.0,"total_display":"39,502.00","total_whole":"39,502","shares_owned_after":176650.0,"shares_owned_after_display":"176,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-04","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4302964,"accession":"0001144204-13-040768","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16700.0,"shares_display":"16,700","price_per_share":1.9905988023952095,"price_display":"1.99","price_state":"stated","total_value":33243.0,"total_display":"33,243.00","total_whole":"33,243","shares_owned_after":161050.0,"shares_owned_after_display":"161,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-03","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4302958,"accession":"0001144204-13-040768","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":1.9231578947368422,"price_display":"1.92","price_state":"stated","total_value":18270.0,"total_display":"18,270.00","total_whole":"18,270","shares_owned_after":145350.0,"shares_owned_after_display":"145,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-02","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4302951,"accession":"0001144204-13-040768","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31500.0,"shares_display":"31,500","price_per_share":1.7452380952380953,"price_display":"1.75","price_state":"stated","total_value":54975.0,"total_display":"54,975.00","total_whole":"54,975","shares_owned_after":136850.0,"shares_owned_after_display":"136,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-01","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4302946,"accession":"0001144204-13-040768","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768#line-22","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","total_whole":"1,500","shares_owned_after":108350.0,"shares_owned_after_display":"108,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-28","filed_date":"2013-07-23","scope":"insider"},{"id":4302943,"accession":"0001144204-13-040768","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768#line-21","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","total_whole":"1,500","shares_owned_after":107350.0,"shares_owned_after_display":"107,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-27","filed_date":"2013-07-23","scope":"insider"},{"id":4302939,"accession":"0001144204-13-040768","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768#line-20","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":4500.0,"total_display":"4,500.00","total_whole":"4,500","shares_owned_after":106350.0,"shares_owned_after_display":"106,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-26","filed_date":"2013-07-23","scope":"insider"},{"id":4302937,"accession":"0001144204-13-040768","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1.4714285714285715,"price_display":"1.47","price_state":"stated","total_value":10300.0,"total_display":"10,300.00","total_whole":"10,300","shares_owned_after":103350.0,"shares_owned_after_display":"103,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-25","filed_date":"2013-07-23","scope":"insider","n_lines":2},{"id":4302931,"accession":"0001144204-13-040768","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768#line-17","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":5560.0,"total_display":"5,560.00","total_whole":"5,560","shares_owned_after":98350.0,"shares_owned_after_display":"98,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-22","filed_date":"2013-07-23","scope":"insider"},{"id":4302927,"accession":"0001144204-13-040768","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768#line-16","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":2250.0,"total_display":"2,250.00","total_whole":"2,250","shares_owned_after":94350.0,"shares_owned_after_display":"94,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-18","filed_date":"2013-07-23","scope":"insider"},{"id":4302924,"accession":"0001144204-13-040768","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001144204-13-040768","line_url":"/filing/0001144204-13-040768#line-15","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Elizabeth Charuvastra & William Shell Family Trust; Shell William","owner_display_name":"Elizabeth Charuvastra & William Shell Family Trust","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":4140.0,"total_display":"4,140.00","total_whole":"4,140","shares_owned_after":92850.0,"shares_owned_after_display":"92,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-15","filed_date":"2013-07-23","scope":"insider"}],"collapsed":true,"next_cursor":"2013-03-15|4302924","ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001420030","name":"Targeted Medical Pharma, Inc.","url":"/issuer/0001420030","role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","n_filings":8,"first_seen":"2013-07-23","last_seen":"2014-05-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001509917","retrieved_at":"2026-08-24T05:23:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}